Compare BEEM & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BEEM | KYNB |
|---|---|---|
| Founded | 2006 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.6M | 32.8M |
| IPO Year | 2018 | 2014 |
| Metric | BEEM | KYNB |
|---|---|---|
| Price | $0.91 | $5.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | $2.50 | ★ $38.50 |
| AVG Volume (30 Days) | ★ 578.4K | 22.5K |
| Earning Date | 11-13-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 40.77 | ★ 9552.08 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $28,236,000.00 | $6,440,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.39 | $14.12 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.82 | $4.85 |
| 52 Week High | $3.09 | $9.66 |
| Indicator | BEEM | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 24.74 | 29.52 |
| Support Level | N/A | N/A |
| Resistance Level | $1.66 | $7.41 |
| Average True Range (ATR) | 0.06 | 0.37 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 24.97 | 17.37 |
Beam Global is a clean-technology innovation company. It develop, design, engineer, manufacture, and sell high-quality, renewably energized infrastructure products for electric vehicle ( EV ) charging, infrastructure for Smart Cities (the interconnected physical and digital elements within a city that utilize technology to enhance efficiency, sustainability, and quality of life for residents), energy security and disaster preparedness and energy-dense battery solutions in safe, compact and form-factors. Additionally, the company manufactures structures with electronic integration such as streetlighting, cell towers and energy infrastructure products as well as power electronics including invertors, charge controllers, power supplies and LED lighting.
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.